| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.8M | -4.9% |
| Cost of Revenue | $11.9M | +23.1% |
| Gross Profit | $14.9M | -19.5% |
| R&D Expense | $10.3M | -2.7% |
| SG&A Expense | $14.1M | -2.2% |
| Operating Income | -$21.8M | -16.3% |
| Net Income | -$20.7M | -13.2% |
| EPS (Basic) | -$0.27 | -3.8% |
| EPS (Diluted) | -$0.27 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.8M | +130.8% |
| Short-term Investments | $19.8M | +0.0% |
| Accounts Receivable | $3.8M | -24.9% |
| Inventory | $8.4M | +7.0% |
| Current Assets | $33.3M | -23.1% |
| Total Assets | $41.9M | -21.5% |
| Current Liabilities | $13.2M | -7.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -8.6% |
| Investing Cash Flow | $19.8M | +189.5% |
| Financing Cash Flow | $81K | -63.2% |
| -3.8% |
| Total Liabilities |
| $20.0M |
| -7.0% |
| Stockholders' Equity | $16.3M | -38.0% |